| James Motroni, CRNA | |
|
280 W Macarthur Blvd, Oakland, CA 94611-5642 | |
| (510) 752-6238 | |
| Not Available |
| Full Name | James Motroni |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 280 W Macarthur Blvd, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326104951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1199 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Motroni, CRNA 280 W Macarthur Blvd, Oakland, CA 94611-5642 Ph: (510) 752-6238 | James Motroni, CRNA 280 W Macarthur Blvd, Oakland, CA 94611-5642 Ph: (510) 752-6238 |
News Archive
Biomedical engineers at UC Davis have developed a plug-in interface for the microfluidic chips that will form the basis of the next generation of compact medical devices. They hope that the "fit to flow" interface will become as ubiquitous as the USB interface for computer peripherals.
Jerry, 9 years old, dissolved into his Game Boy while his father described his attentional difficulties to the family pediatrician.
BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., today announced the successful completion of their previously announced merger of Cell Genesys with and into BioSante, with BioSante as the surviving company, under which BioSante now has acquired all of the outstanding shares of Cell Genesys common stock.
Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 2 days ago
Diana Hiros, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6238 | |
Annette Chenevey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6238 | |
David P Birch, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6238 | |
Sandra Sue Schmit, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6238 | |
Ray Neil Mitsuno, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3600 Broadway, Oakland, CA 94611 Phone: 510-752-1000 | |
Rhaven Danielle Mciver, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3100 Telegraph Ave, Oakland, CA 94609 Phone: 510-879-9200 | |
Mrs. Polly Van Sant Soler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1800 Harrison St Fl 7, Oakland, CA 94612 Phone: 510-625-6262 |